why choose us

First received: October 25, 2023

Clinical Trial: Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diffuse Large B-cell Lymphoma

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r DLBCL Clinical Research

Brief Summary: A Study of Metabolically Armed CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma

Read more